A carregar...

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients

SUMMARY: Bone mineral density (BMD) sometimes cannot be improved by long-term bisphosphonate (BP) therapy in osteoporosis (OP). This study showed that lumbar as well as hip BMD significantly increased after denosumab treatment in patients not responsive to BPs. Thus, denosumab may be a strong OP tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Osteoporos Int
Main Authors: Kamimura, M., Nakamura, Y., Ikegami, S., Uchiyama, S., Kato, H., Taguchi, A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer London 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5269470/
https://ncbi.nlm.nih.gov/pubmed/27650642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-016-3764-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!